Xencor (XNCR) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

XNCR Stock Forecast

Xencor stock forecast is as follows: an average price target of $30.00 (represents a 24.33% upside from XNCR’s last price of $24.13) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

XNCR Price Target

The average price target for Xencor (XNCR) is $30.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $30.00 to $30.00. This represents a potential 24.33% upside from XNCR's last price of $24.13.

XNCR Analyst Ratings

Buy

According to 6 Wall Street analysts, Xencor's rating consensus is 'Buy'. The analyst rating breakdown for XNCR stock is 1 'Strong Buy' (16.67%), 5 'Buy' (83.33%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Xencor Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Dec 02, 2024	Edward Tenthoff	Piper Sandler	$30.00	$25.60	17.19%	24.33%
Jun 14, 2024	Etzer Darout	BMO Capital	$32.00	$20.89	53.15%	32.62%
Jun 14, 2024	Gregory Renza	RBC Capital	$31.00	$20.99	47.69%	28.47%
Apr 16, 2024	Kaveri Pohlman	BTIG	$38.00	$20.11	88.96%	57.48%
Oct 04, 2021	Charles Zhu	Guggenheim	$54.00	$35.52	52.03%	123.79%
May 05, 2021	Dane Leone	Raymond James	$58.00	$40.76	42.30%	140.36%

The latest Xencor stock forecast, released on Dec 02, 2024 by Edward Tenthoff from Piper Sandler, set a price target of $30.00, which represents a 17.19% increase from the stock price at the time of the forecast ($25.60), and a 24.33% increase from XNCR last price ($24.13).

Xencor Price Target by Period

	1M	3M	12M
# Anlaysts	1	1	4
Avg Price Target	$30.00	$30.00	$32.75
Last Closing Price	$24.13	$24.13	$24.13
Upside/Downside	24.33%	24.33%	35.72%

In the current month, the average price target of Xencor stock is $30.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 24.33% increase as opposed to Xencor's last price of $24.13. This month's average price target is down 0.00% compared to last quarter, and down -8.40% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Sep 26, 2024	RBC Capital	Outperform	Outperform	Hold
Jun 14, 2024	BMO Capital	Outperform	Outperform	Hold
Jun 14, 2024	RBC Capital	Outperform	Outperform	Hold
May 10, 2024	Wedbush	Buy	Buy	Hold
Apr 16, 2024	Wedbush	Buy	Buy	Hold
Apr 16, 2024	BTIG	Buy	Buy	Hold
Feb 28, 2024	Wedbush	Buy	Buy	Hold
Feb 28, 2024	RBC Capital	Underperform	Underperform	Hold
Dec 06, 2022	Cowen & Co.		Outperform	Initialise
Oct 13, 2022	Raymond James		Strong Buy	Upgrade

Xencor's last stock rating was published by RBC Capital on Sep 26, 2024. The company gave XNCR a "Outperform" rating, the same as its previous rate.

Xencor Financial Forecast

Xencor Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$44.69M	$59.16M	$45.52M	$18.96M	$21.61M	$27.30M	$30.18M	$85.50M	$154.01M	$19.68M	$67.45M	$33.97M	$41.85M	$35.37M	$13.09M	$32.38M	$3.52M	$21.76M
Avg Forecast	$30.00M	$30.00M	$30.00M	$30.00M	$23.19M	$16.80M	$17.60M	$16.51M	$20.42M	$14.59M	$20.00M	$23.07M	$77.63M	$30.01M	$26.25M	$28.72M	$20.07M	$21.05M	$34.01M	$26.14M	$76.29M	$20.74M	$18.51M	$16.01M	$30.51M	$36.01M	$11.71M	$14.64M	$14.31M	$6.72M
High Forecast	$45.13M	$45.13M	$45.13M	$45.13M	$34.88M	$25.28M	$26.47M	$25.50M	$25.87M	$14.76M	$20.56M	$23.07M	$121.33M	$30.01M	$39.49M	$43.21M	$30.19M	$21.05M	$34.01M	$26.14M	$76.29M	$20.74M	$18.51M	$16.01M	$30.51M	$36.01M	$11.71M	$14.64M	$14.31M	$6.72M
Low Forecast	$17.81M	$17.81M	$17.81M	$17.81M	$13.77M	$9.98M	$10.45M	$8.52M	$16.21M	$14.42M	$19.44M	$23.07M	$11.03M	$30.01M	$15.59M	$17.06M	$11.92M	$21.05M	$34.01M	$26.14M	$76.29M	$20.74M	$18.51M	$16.01M	$30.51M	$36.01M	$11.71M	$14.64M	$14.31M	$6.72M
# Analysts	2	2	2	2	1	1	1	4	6	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	4	7	6	5	5
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.58%	1.97%	1.73%	0.66%	1.08%	1.30%	0.89%	3.27%	2.02%	0.95%	3.64%	2.12%	1.37%	0.98%	1.12%	2.21%	0.25%	3.24%

Xencor's average Quarter revenue forecast for Mar 24 based on 4 analysts is $23.07M, with a low forecast of $23.07M, and a high forecast of $23.07M. XNCR's average Quarter revenue forecast represents a -48.37% decrease compared to the company's last Quarter revenue of $44.69M (Dec 23).

Xencor EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	4	6	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	4	7	6	5	5
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-33.47M	$-18.27M	$-26.00M	$-59.37M	$-42.59M	$-41.41M	$-19.23M	$32.07M	$75.17M	$-38.20M	$54.00M	$-849.00K	$1.52M	$-11.10M	$-33.58M	$-6.70M	$-25.98M	$-9.50M
Avg Forecast	$-8.78M	$-8.78M	$-8.78M	$-8.78M	$-6.79M	$-4.92M	$-5.15M	$-4.83M	$-5.98M	$-4.27M	$-5.85M	$-6.75M	$-22.72M	$-8.78M	$-7.68M	$-8.40M	$-5.87M	$-6.88M	$-11.12M	$-8.55M	$-24.95M	$-6.78M	$-6.05M	$-1.48M	$-9.98M	$-11.77M	$-3.83M	$-9.84M	$-4.68M	$-2.20M
High Forecast	$-5.21M	$-5.21M	$-5.21M	$-5.21M	$-4.03M	$-2.92M	$-3.06M	$-2.49M	$-4.74M	$-4.22M	$-5.69M	$-6.75M	$-3.23M	$-8.78M	$-4.56M	$-4.99M	$-3.49M	$-6.88M	$-11.12M	$-8.55M	$-24.95M	$-6.78M	$-6.05M	$-1.19M	$-9.98M	$-11.77M	$-3.83M	$-7.87M	$-4.68M	$-2.20M
Low Forecast	$-13.20M	$-13.20M	$-13.20M	$-13.20M	$-10.21M	$-7.40M	$-7.75M	$-7.46M	$-7.57M	$-4.32M	$-6.02M	$-6.75M	$-35.50M	$-8.78M	$-11.56M	$-12.64M	$-8.83M	$-6.88M	$-11.12M	$-8.55M	$-24.95M	$-6.78M	$-6.05M	$-1.78M	$-9.98M	$-11.77M	$-3.83M	$-11.81M	$-4.68M	$-2.20M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.47%	2.08%	3.38%	7.06%	7.25%	6.02%	1.73%	-3.75%	-3.01%	5.63%	-8.92%	0.57%	-0.15%	0.94%	8.77%	0.68%	5.55%	4.32%

4 analysts predict XNCR's average Quarter EBITDA for Jun 22 to be $-11.12M, with a high of $-11.12M and a low of $-11.12M. This is -134.67% lower than Xencor's previous annual EBITDA (Mar 22) of $32.07M.

Xencor Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	4	6	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	4	7	6	5	5
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-19.10M	$-24.27M	$-21.95M	$-59.92M	$-12.04M	$-32.76M	$-39.95M	$23.59M	$73.06M	$-40.19M	$52.25M	$-2.49M	$-13.69K	$-12.55M	$-35.02M	$-8.07M	$-26.91M	$-10.22M
Avg Forecast	$-138.93M	$-37.13M	$-27.53M	$-23.05M	$-71.17M	$-52.61M	$-52.39M	$-50.90M	$-50.17M	$-62.82M	$-53.19M	$90.05M	$-6.79M	$-46.50M	$-51.03M	$71.18M	$866.88M	$-41.70M	$-30.46M	$56.27M	$1.73M	$-38.92M	$-36.19M	$-4.34M	$-23.36M	$-13.79M	$-31.64M	$-11.86M	$-25.35M	$-33.64M
High Forecast	$-65.57M	$-17.52M	$-12.99M	$-10.88M	$-33.59M	$-24.83M	$-24.73M	$-47.43M	$-36.87M	$-29.65M	$-25.10M	$108.06M	$25.46M	$-21.95M	$-24.09M	$85.42M	$1.04B	$-41.70M	$-30.46M	$67.53M	$1.73M	$-38.92M	$-36.19M	$-3.47M	$-23.36M	$-13.79M	$-31.64M	$-9.48M	$-25.35M	$-33.64M
Low Forecast	$-230.01M	$-61.48M	$-45.58M	$-38.16M	$-117.83M	$-87.09M	$-86.74M	$-58.42M	$-64.68M	$-104.01M	$-88.07M	$72.04M	$-35.64M	$-76.99M	$-84.49M	$56.95M	$693.50M	$-41.70M	$-30.46M	$45.02M	$1.73M	$-38.92M	$-36.19M	$-5.21M	$-23.36M	$-13.79M	$-31.64M	$-14.23M	$-25.35M	$-33.64M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	2.81%	0.52%	0.43%	-0.84%	-0.01%	0.79%	1.31%	0.42%	42.29%	1.03%	-1.44%	0.57%	0.00%	0.91%	1.11%	0.68%	1.06%	0.30%

Xencor's average Quarter net income forecast for Jun 22 is $-30.46M, with a range of $-30.46M to $-30.46M. XNCR's average Quarter net income forecast represents a -229.11% decrease compared to the company's last Quarter net income of $23.59M (Mar 22).

Xencor SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	4	6	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	4	7	6	5	5
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$15.27M	$12.49M	$11.46M	$13.95M	$12.75M	$12.37M	$11.09M	$11.27M	$11.38M	$10.37M	$8.86M	$8.23M	$7.60M	$7.64M	$7.23M	$7.22M	$6.75M	$6.27M
Avg Forecast	$6.86M	$6.86M	$6.86M	$6.86M	$5.30M	$3.84M	$4.03M	$3.78M	$4.67M	$3.34M	$4.57M	$5.28M	$17.76M	$6.86M	$6.01M	$6.57M	$4.59M	$4.53M	$7.32M	$5.62M	$16.41M	$4.46M	$3.98M	$14.36M	$6.56M	$7.74M	$2.52M	$10.60M	$3.08M	$1.45M
High Forecast	$10.32M	$10.32M	$10.32M	$10.32M	$7.98M	$5.78M	$6.06M	$5.83M	$5.92M	$3.38M	$4.70M	$5.28M	$27.75M	$6.86M	$9.03M	$9.88M	$6.91M	$4.53M	$7.32M	$5.62M	$16.41M	$4.46M	$3.98M	$17.24M	$6.56M	$7.74M	$2.52M	$12.72M	$3.08M	$1.45M
Low Forecast	$4.08M	$4.08M	$4.08M	$4.08M	$3.15M	$2.28M	$2.39M	$1.95M	$3.71M	$3.30M	$4.45M	$5.28M	$2.52M	$6.86M	$3.57M	$3.90M	$2.73M	$4.53M	$7.32M	$5.62M	$16.41M	$4.46M	$3.98M	$11.49M	$6.56M	$7.74M	$2.52M	$8.48M	$3.08M	$1.45M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.86%	1.82%	1.91%	2.12%	2.78%	2.73%	1.52%	2.00%	0.69%	2.33%	2.23%	0.57%	1.16%	0.99%	2.87%	0.68%	2.19%	4.33%

Xencor's average Quarter SG&A projection for Mar 24 is $5.28M, based on 4 Wall Street analysts, with a range of $5.28M to $5.28M. The forecast indicates a -65.44% fall compared to XNCR last annual SG&A of $15.27M (Dec 23).

Xencor EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	4	6	3	5	4	8	4	5	4	4	3	4	3	5	4	5	4	5	4	7	6	5	5
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.31	$-0.40	$-0.37	$-1.00	$-0.20	$-0.55	$-0.67	$0.40	$1.25	$-0.69	$0.90	$-0.04	$-0.00	$-0.22	$-0.61	$-0.14	$-0.47	$-0.18
Avg Forecast	$-2.17	$-0.58	$-0.43	$-0.36	$-1.11	$-0.82	$-0.82	$-0.80	$-0.78	$-0.98	$-0.83	$-0.83	$-0.11	$-0.73	$-0.80	$-0.66	$-0.79	$-0.68	$-0.49	$-0.55	$0.03	$-0.63	$-0.59	$-0.67	$-0.38	$-0.22	$-0.51	$-0.38	$-0.41	$-0.55
High Forecast	$-1.02	$-0.27	$-0.20	$-0.17	$-0.52	$-0.39	$-0.39	$-0.74	$-0.58	$-0.46	$-0.39	$-0.39	$0.40	$-0.34	$-0.38	$-0.31	$-0.37	$-0.68	$-0.49	$-0.55	$0.03	$-0.63	$-0.59	$-0.67	$-0.38	$-0.22	$-0.51	$-0.38	$-0.41	$-0.55
Low Forecast	$-3.59	$-0.96	$-0.71	$-0.60	$-1.84	$-1.36	$-1.35	$-0.91	$-1.01	$-1.62	$-1.38	$-1.37	$-0.56	$-1.20	$-1.32	$-1.10	$-1.31	$-0.68	$-0.49	$-0.55	$0.03	$-0.63	$-0.59	$-0.67	$-0.38	$-0.22	$-0.51	$-0.38	$-0.41	$-0.55
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	2.92%	0.55%	0.46%	1.51%	0.25%	0.81%	1.36%	-0.73%	44.63%	1.09%	-1.53%	0.06%	0.00%	0.98%	1.19%	0.37%	1.14%	0.33%

According to 4 Wall Street analysts, Xencor's projected average Quarter EPS for Jun 22 is $-0.49, with a low estimate of $-0.49 and a high estimate of $-0.49. This represents a -223.48% decrease compared to XNCR previous annual EPS of $0.40 (Mar 22).

Xencor Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
STRO	Sutro Biopharma	$2.09	$13.00	522.01%	Buy
KROS	Keros Therapeutics	$18.00	$102.00	466.67%	Buy
LRMR	Larimar Therapeutics	$4.32	$17.00	293.52%	Buy
ANAB	AnaptysBio	$15.99	$49.83	211.63%	Buy
MLYS	Mineralys Therapeutics	$12.35	$30.00	142.91%	Buy
KURA	Kura Oncology	$9.74	$23.33	139.53%	Buy
SNDX	Syndax Pharmaceuticals	$13.63	$31.67	132.36%	Buy
ERAS	Erasca	$2.63	$6.00	128.14%	Buy
IDYA	IDEAYA Biosciences	$26.33	$53.33	102.54%	Buy
MRUS	Merus	$44.90	$81.25	80.96%	Buy
PCVX	Vaxcyte	$89.86	$148.80	65.59%	Buy
REPL	Replimune Group	$11.72	$19.00	62.12%	Buy
EWTX	Edgewise Therapeutics	$30.17	$46.25	53.30%	Buy
PTGX	Protagonist Therapeutics	$40.69	$57.33	40.89%	Buy
MGTX	MeiraGTx	$6.40	$9.00	40.63%	Buy
ACLX	Arcellx	$82.03	$111.60	36.05%	Buy
NUVL	Nuvalent	$88.10	$114.80	30.31%	Buy
XNCR	Xencor	$25.04	$30.00	19.81%	Buy
VRDN	Viridian Therapeutics	$20.82	$22.75	9.27%	Buy

XNCR Forecast FAQ

Is Xencor a good buy?

Yes, according to 6 Wall Street analysts, Xencor (XNCR) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 5 'Buy' recommendations, accounting for 100.00% of XNCR's total ratings.

What is XNCR's price target?

Xencor (XNCR) average price target is $30 with a range of $30 to $30, implying a 24.33% from its last price of $24.13. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Xencor stock go up soon?

According to Wall Street analysts' prediction for XNCR stock, the company can go up by 24.33% (from the last price of $24.13 to the average price target of $30), up by 24.33% based on the highest stock price target, and up by 24.33% based on the lowest stock price target.

Can Xencor stock reach $40?

XNCR's average twelve months analyst stock price target of $30 does not support the claim that Xencor can reach $40 in the near future.

What is Xencor's current price target trend?

1 Wall Street analyst forecast a $30 price target for Xencor (XNCR) this month, up 24.33% from its last price of $24.13. Compared to the last 3 and 12 months, the average price target increased by 24.33% and increased by 35.72%, respectively.

What are Xencor's analysts' financial forecasts?

Xencor's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $74.11M (high $112.14M, low $42.72M), average EBITDA is $-21.683M (high $-12.5M, low $-32.81M), average net income is $-227M (high $-131M, low $-350M), average SG&A $16.95M (high $25.65M, low $9.77M), and average EPS is $-3.547 (high $-2.039, low $-5.468). XNCR's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $120M (high $180.52M, low $71.26M), average EBITDA is $-35.111M (high $-20.849M, low $-52.818M), average net income is $-227M (high $-107M, low $-375M), average SG&A $27.45M (high $41.29M, low $16.3M), and average EPS is $-3.54 (high $-1.671, low $-5.861).

Did the XNCR's actual financial results beat the analysts' financial forecasts?

Based on Xencor's last annual report (Dec 2023), the company's revenue was $168.34M, beating the average analysts forecast of $162.62M by 3.52%. Apple's EBITDA was $-138M, beating the average prediction of $-47.58M by 191.04%. The company's net income was $-126M, beating the average estimation of $-33.14M by 280.46%. Apple's SG&A was $53.38M, beating the average forecast of $37.2M by 43.49%. Lastly, the company's EPS was $-2.08, missing the average prediction of $-2.293 by -9.27%. In terms of the last quarterly report (Dec 2023), Xencor's revenue was $44.69M, missing the average analysts' forecast of $77.63M by -42.44%. The company's EBITDA was $-33.466M, beating the average prediction of $-22.715M by 47.33%. Xencor's net income was $-19.1M, beating the average estimation of $-6.788M by 181.37%. The company's SG&A was $15.27M, missing the average forecast of $17.76M by -14.01%. Lastly, the company's EPS was $-0.31, beating the average prediction of $-0.106 by 192.37%